Showing results (171-180 of 190) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|June 2, 2011
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcomeHong Shi, Melanie Bevier, Robert Johansson, et al.The Lancet. Oncology|July 8, 2015
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-OncologyKhê Hoang-Xuan, Eric Bessell, Jacoline Bromberg, et al.Kidney International|March 20, 2019
Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladderNeil A Roberts, Emma N Hilton, Filipa M Lopes, et al.Neuro-Oncology|August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.Neuro-Oncology Practice|December 14, 2020
Determining medical decision-making capacity in brain tumor patients: why and how?Andrea Pace, Johan A F Koekkoek, Martin J van den Bent, et al.International Journal of Cancer|November 2, 2012
Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association studyBeatrice Melin, Anna M Dahlin, Ulrika Andersson, et al.The Lancet. Oncology|May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomasMichael Weller, Martin van den Bent, Jörg C Tonn, et al.Nature Genetics|August 2, 2011
Common variation at 10p12.31 near MLLT10 influences meningioma riskSara E Dobbins, Peter Broderick, Beatrice Melin, et al.Cancer Research|November 1, 2011
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene ConsortiumSanjay Shete, Ching C Lau, Richard S Houlston, et al.Neuro-Oncology|April 17, 2018
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastomaBenjamin M Ellingson, Lauren E Abrey, Sarah J Nelson, et al.Pageof 19